26 May 2017 | 2:34 AM
 

Divi`s Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 532488 | NSE Symbol: DIVISLAB
551.30
-6.05
(-1.08 %)
25 May 2017 | 03:56 PM
Change company
  • Open (Rs)
    559.96
  • Prev. close (Rs.)
    557.35
  • High (Rs.)
    559.96
  • Low (Rs.)
    540.60
  • 52W H (Rs.)
    1,380.00
  • 52W L (Rs.)
    540.60
  • Volume (Rs.)
    155836
  • MCap (Rs in Cr.)
    14,635.31
553.85
-5.00
(-0.89 %)
  • Open (Rs)
    553.00
  • High (Rs)
    563.60
  • Low (Rs)
    542.05
  • Prev. close(Rs)
    558.85
  • Contracts Tra.
    71,48,400
  • Turnover (Cr.)
    394
  • Open Interest
    98,63,400
  • Open Int. chg
    38,16,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
64.15
Operating Margin (%)
37.40
Gross Profit Margin (%)
33.04
Net Profit Margin (%)
27.33
Total Debt/Equity
0.01
Dividend payout Ratio (Net Profit)
37.52
Earning Retention Ratio
62.48

News

24 Apr 2017 - 11:20:00-Drug firm Divi's Laboratories said that the US health regulator has issued a warning letter to ...
24 Apr 2017 - 09:51:00-Shares of Divi's Laboratories dipped nearly 4 per cent hitting 52-week low in early trade on the...
22 Mar 2017 - 11:51:00-Shares of Divi's Laboratories continued losing streak of the second day and tanked over 3 per ce...
21 Mar 2017 - 12:07:00-Drug firm Divi's Laboratories Ltd on Tuesday said the US health regulator has issued an import a...

Announcements

15-May-2017
Divi`s Lab - Board Meeting On 05 262017
15-May-2017
Divi`s Lab - Board to consider FY17 Results & Dividend on May 26 2017
22-Apr-2017
Divi`s Lab - Updates
08-Apr-2017
Divi`s Lab - Updates
07-Apr-2017
Divi`s Lab - Compliance Certificate For Half Year Ended 31St March 2017

Religare Research

25 May 2017 | 11:21 AM
SML Isuzu reported in-line Q4FY17 revenue growth; however Net profit took a hit due to BSIV implemen...
25 May 2017 | 10:58 AM
Agri Fundamental and Technical report
25 May 2017 | 10:09 AM
The Indian rupee rose against the dollar as banks sold the greenback in thin volume trade, even as t...
25 May 2017 | 09:31 AM
• Gold up after Fed minutes suggest little change in U.S. rate outlook • Crude futures settle lower ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
24,33,441 575.29 81.97 1.81
24,33,441 575.29 30.22 1.81
24,33,441 575.29 81.97 1.81
24,33,441 575.29 21.95 0.70
24,33,441 575.29 84.76 1.81

Shareholding Pattern

       
Promotors52.07%
Mutual Funds/UTI13.75%
FI/Banks0.45%
Insurance0.45%
FII17.22%
Government0.00%
Others6.72%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,694.50(1.69)
3356
 Dr. Reddy`s Laboratories Ltd.
2,427.30(-3.70)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,368.80(-1.28)
3317
 Alkem Laboratories Ltd.
1,827.85(-0.10)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Divi`s Laboratories Ltd.-95.45-216.80-605.85
NIFTY(S&P CNX)203.15613.051,395.45
BSE SENSEX806.791,937.154,433.69
BSE 50024.95830.562,002.35

Corporate Details

Key Personal
Kiran S Divi
President & Director
Madhusudana Rao Divi
Director - Projects
Murali K Divi
Chairman & Managing Director
Key Address
Registered Office
1-72/23(P)/DIVIS/303 Divi Towers Cyber Hills Gachibowli,Hyderabad,Telangana

Tel:040-23786300, Fax:040-23786460

mail@divislaboratories.com
http://www.divislaboratories.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Divi`s Laboratories Ltd. that will help you decide whether to buy, sell or hold Divi`s Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Divi`s Laboratories Ltd.